Introduction
The p53 tumor suppressor represents a central defense against human cancer (Vousden and Lane, 2007) . Its inactivation is one of the most common alterations in human tumors, and numerous studies have established the tumor suppressing properties of p53 (Toledo and Wahl, 2006) . A principal mechanism of this tumor suppression is the induction of growth arrest and/or apoptosis in cells that suffer DNA damage (Vousden and Lu, 2002) . In this way, p53 inhibits the propagation of cells that harbor potentially oncogenic DNA alterations. In addition, other forms of stress have been shown to activate p53-dependent responses (Vousden and Lane, 2007) . One example is prolonged activation of the mitotic checkpoint, which elicits a p53-dependent cell cycle arrest . This 'postmitotic' response, so named because growth arrest is actually imposed on cells that have exited from prolonged mitosis, has been observed in numerous cell systems (Cross et al., 1995; Minn et al., 1996; Di Leonardo et al., 1997; Lanni and Jacks, 1998; Andreassen et al., 2001; Rajagopalan et al., 2004; Chan et al., 2008) . Despite the ubiquity of the postmitotic response, its mechanism is not well defined (Stukenberg, 2004; .
One clue to the function of the postmitotic response may be that prolonged activation of the mitotic checkpoint has been causally implicated in tumorigenesis (Dalton and Yang, 2009) . Indeed, mitosis is frequently prolonged in cancer cells, and several genetic and epigenetic defects, which cause mitotic arrest, can contribute to cancer (Dalton and Yang, 2009) . For some of these defects, such as inactivation of Rb and hCDC4, oncogenic activation of c-Myc, and the presence of supernumerary chromosomes and/or centrosomes, prolonged mitosis is one of many cellular effects, which may or may not be oncogenic (Hernando et al., 2004; Rajagopalan et al., 2004; Fujiwara et al., 2005; Yang et al., 2008) . However, mitotic arrest and cancer also develop in mice overexpressing Mad2, a protein principally involved in mitotic checkpoint signaling, providing strong evidence that prolonged mitotic checkpoint activation can directly promote tumorigenesis (Sotillo et al., 2007) . Accordingly, the p53-dependent postmitotic response may serve to inhibit the propagation of cells, which acquire oncogenic properties during prolonged activation of the mitotic checkpoint.
What aspects of mitotic arrest might be oncogenic? Certainly, one candidate is aneuploidy and/or tetraploidy resulting from the chromosome missegregation and/or cytokinesis failure, which can follow prolonged activation of the mitotic checkpoint . Indeed, in some contexts, aneuploidy and tetraploidy have themselves been causally implicated in tumorigenesis (Fujiwara et al., 2005; Weaver et al., 2007) . At the same time, we and others recently found that mitotic arrest can induce structural chromosome changes resulting from double-stranded DNA breaks (Dalton et al., 2007; Quignon et al., 2007; Stevens et al., 2007) . Given the role of structural chromosome aberrations in tumorigenesis, these observations suggest that one way prolonged mitosis could promote cancer is through introduction of DNA breaks. By extension, one function of the p53-dependent postmitotic response may be to prevent this structural chromosome instability. To investigate this possibility, we have measured structural chromosome instability resulting from mitotic arrest in human colon cancer cells and normal fibroblasts, which differ only in their p53 status. Our results show that, by imposing growth arrest and/or apoptosis in cells whose DNA is damaged during mitotic arrest, p53 suppresses structural chromosome instability after prolonged mitotic checkpoint activation in human cells.
Results

Both p53
þ / þ and p53 À/À cells acquire g-H2AX foci during mitotic arrest To examine the function of p53 in structural chromosome instability after prolonged mitosis, we first asked whether p53 influences the acquisition of DNA damage during pharmacologic induction of mitotic arrest in isogenic p53
þ / þ and p53 À/À HCT116 cells (Bunz et al., 1998) . On treatment with the microtubule-depolymerizing agent nocodazole, both p53 þ / þ and p53 À/À cells exhibited a transient rise in mitotic index, which peaked at 12-18 h ( Figure 1a ). This was followed by 'mitotic slippage,' a process whereby mitotically arrested cells return to interphase without undergoing cell division ( Figure 1a ) (Rieder and Maiato, 2004) . To determine the extent of DNA damage acquired during this arrest, we measured the formation of g-H2AX, the phosphorylated form of histone H2AX, which forms around sites of DNA breaks (Rogakou et al., 1999) . Similar to our earlier findings (Dalton et al., 2007) , nocodazolearrested prometaphase p53 þ / þ cells showed an increase in g-H2AX foci, as compared with prometaphase controls (Figure 1b) . Increased g-H2AX foci were also observed in p53 À/À cells (Figure 1b) , and flow cytometric analysis showed that the magnitude of this increase was comparable with p53 þ / þ cells ( Figure 1c ). To determine whether increased g-H2AX was indeed the result of mitotic arrest, and not some other effects of nocodazole, we performed the assay after siRNA-mediated knockdown of the Eg5 mitotic kinesin protein, whose inactivation prevents centrosome separation, produces a monopolar spindle, and thereby induces mitotic arrest (Koller et al., 2006) . Indeed, knockdown of Eg5 produced an elevated mitotic index, monopolar spindles, and increased g-H2AX foci in mitotic p53 þ / þ and p53 À/À cells (Figures 1d-f) . Thus, both pharmacologic and genetic manipulations, which provoke mitotic arrest through distinct mechanisms, produce evidence of DNA breaks in p53 þ / þ and p53 À/À HCT116 cells.
p53 inhibits the polyploidization and survival of postmitotic cells Having observed that p53 does not influence the acquisition of DNA damage during mitotic arrest, we next investigated whether the cellular consequences of this damage are dependent on p53. We first determined the fates of p53 þ / þ and p53 À/À cells after nocodazole treatment. Similar to results from earlier studies (Kim et al., 2004; Vogel et al., 2004; Castedo et al., 2006) , p53 À/À cells exhibited greater polyploidization and reduced apoptosis when compared with p53 þ / þ cells during 48 h nocodazole (Figures 2a-e ; Supplementary Figure S1 ). As the specificity of gene targeting in cancer cells is not always certain (Pfleghaar et al., 2005; Matoba et al., 2006) , we independently confirmed the p53 dependence of these phenotypes using miRNA (Supplementary Figure S2 ). Moreover, because short-term rates of apoptosis do not always correspond to long-term rates of survival (Bunz et al., 1999) , we also determined the clonogenicity of these nocodazole-treated cells. This analysis revealed that colony survival of p53
À/À cells exposed to 48 h nocodazole, while low overall, was fivefold of that of p53 þ / þ cells ( Figure 2f ). Collectively, these data indicate that p53 inhibits polyploidization, promotes apoptosis, and suppresses clonogenicitiy after pharmacologic induction of mitotic arrest in HCT116 cells.
p53 inhibits structural chromosome instability in postmitotic cells By inducing growth arrest and apoptosis in cells, which have undergone prolonged mitotic arrest, p53 could act to suppress the structural chromosome changes, which result from DNA damage acquired during prolonged mitosis. If true, p53 À/À cells made polyploid after prolonged mitosis might be expected to exhibit not only greater survival, but also more structural chromosome aberrations than their p53 þ / þ counterparts. To test this hypothesis, we examined p53 þ / þ and p53 À/À HCT116 cells for the presence of chromosome aberrations after 48 h of nocodazole. Consistent with our earlier findings (Dalton et al., 2007) , nocodazole-induced polyploid HCT116 cells exhibited multiple types of structural chromosome aberrations (Figure 3) . Notably, nocodazole-treated p53 À/À cells exhibited a 50% higher burden of aberrations than p53 þ / þ cells (Po0.0001) (Figure 3 ). This result suggests that p53 preferentially inhibits the polyploidization and survival of those cells that suffer the greatest DNA damage during mitotic arrest. In this way, p53 suppresses structural chromosome instability after mitotic arrest in HCT116 cells.
Polyploidy is not responsible for structural chromosome instability after mitotic arrest To address the possibility that the polyploid state itself might elicit structural chromosome changes , we determined the cell fate and genomic stability of p53 þ / þ and p53 À/À HCT116 cells treated with the myosin inhibitor blebbistatin, which creates polyploid cells through inhibition of cytokinesis without p53 and suppression of chromosomal instability WB Dalton et al provoking mitotic arrest (Wong and Stearns, 2005) . In contrast to nocodazole, blebbistatin was capable of producing polyploidy without significant cell death, cell cycle arrest, or increased chromosome aberrations (Figures 4a-c) . Moreover, no difference in these parameters was observed between p53 þ / þ and p53 (Figures 4a-c) . This result indicates that it is prolonged mitotic arrest, and not polyploidy per se, that elicits significant DNA damage and p53-dependent suppression of structural chromosome instability in nocodazole-treated HCT116 cells. Interestingly, although the total number of breaks per chromosome was not increased by blebbistatin treatment, the frequencies of certain aberrations did change ( Figure 4c ). This pattern was also observed after cytokinesis inhibition using dihydrocytochalasin B (unpublished observations). Thus, although polyploidization itself does not account for the observed structural chromosome instability after prolonged mitotic arrest, it may be that polyploidization, or pharmacologic inhibition of cytokinesis, may induce some degree of DNA damage.
p53 suppresses structural chromosome instability after mitotic arrest in normal human fibroblasts To test whether p53 suppresses structural chromosome instability after mitotic arrest in untransformed human cells, we examined the response to nocodazole of human diploid fibroblasts (HDFs) in which p53 was silenced through lentivirus-mediated expression of miRNAs ( Figure 5a ). In HDFs expressing either p53 or control miRNAs, nocodazole produced an increase in g-H2AX foci during mitotic arrest ( Figure 5b ). Thus, as in HCT116 cells, p53 does not influence the acquisition of DNA damage during mitotic arrest in normal human cells. Also similar to HCT116 cells, HDFs expressing p53 miRNA exhibited an increase in polyploidization (3.5-to 7.5-fold, Po0.05) and structural chromosome instability (2.6-to 2.8-fold, Po0.01) after nocodazole treatment, as compared with control miRNA (Figures 5c-e). In addition to harboring chromosome aberrations such as fragments and dicentrics, a minority of HDFs also exhibited evidence of chromosome pulverization, which can occur when micronuclei enter mitosis prematurely (Supplementary Figure S3 ) (Kato and Sandberg, 1967; Ikeuchi et al., 1972) . Nocodazole-induced cell death, however, did not seem to be influenced by p53 knockdown in HDFs (Supplementary Figure S4) , showing that the function of p53 on apoptosis after prolonged mitotic arrest is cell-type dependent, as discussed earlier. These data, therefore, show that, by inducing postmitotic cell cycle arrest, p53 suppresses structural chromosome instability after mitotic arrest in untransformed, as well as transformed, human cells. þ / þ ; maroon bars, p53 À/À ) 24 h after transfection with Eg5-specific, or control, siRNA, as determined by MPM-2 flow cytometry. Means and s.e.m.s are from two independent experiments. *, Po0.05, for t-tests, as compared with control. (f) Images of prometaphase cells stained for g-H2AX and a-tubulin 24 h after transfection with Eg5-specific, or control, siRNA.
p53 suppresses structural chromosome instability in spontaneous polyploids Interestingly, while performing cytogenetic analysis of HCT116 cells, we noticed that many spontaneous polyploid p53 À/À cells contained chromosome aberrations, including chromosome fragments, dicentrics, and chromatid breaks (Figure 6a ). Indeed, quantification revealed a 2.8-fold increase in the number of breaks per chromosome in polyploid (8N) vs diploid (4N)
p53
À/À cells (Po0.0001) (Figure 6a ). Color karyotyping of these spontaneous p53 À/À polyploids (44N) confirmed the presence of cells with chromosome fragments and chromosome rearrangements (Figure 6c ). In contrast, spontaneous p53 þ / þ polyploids did not exhibit an elevated frequency of chromosome aberrations, when compared with p53 þ / þ diploid cells (Figure 6a) . Moreover, we found that, while of low overall abundance, spontaneous polyploid mitotic cells were threefold more (b)) during 48 h nocodazole treatment. Cells that were entirely negative for the MPM-2 phosphoepitope were found, through fluorescent microscopy, to be apoptotic (Supplementary Figure S1 ). Means and s.e.m.s are from 2-3 independent experiments. *, Po0.05, **, Po0.01 for t-tests. (e) Western blot analysis of p53 and cleaved PARP levels during 48 h nocodazole. Actin was used as a loading control. (f) Example of colony survival after 48 h nocodazole (left panel) and its quantification (right panel). % survival is the number of nocodazole-treated colonies divided by the number of control colonies, although more sparse control flasks were used for quantification (see Materials and methods). Means and s.e.m.s are from three independent experiments. **, Po0.01 for t-test.
, as compared with p53 þ / þ , cells (Figure 6b) , consistent with earlier studies (Bunz et al., 2002 , Pantic et al., 2006 . These findings thus indicate that, in HCT116 cells, p53 suppresses both the frequency and the structural chromosome instability of spontaneous polyploids.
Mitotic slippage after prolonged mitosis occurs spontaneously in p53
À/À HCT116 cells Although the origin of spontaneously damaged p53 À/À polyploids is unknown, one possibility is that they arise from cells that undergo mitotic slippage after mitotic arrest, for example because of the appearance of spontaneous spindle defects, which we earlier observed at low frequency in HCT116 cells (Dalton et al., 2007) . To examine this possibility, we examined mitotic progression using time-lapse videomicroscopy. This analysis revealed that 4% (24/592) of mitoses resulted in spontaneous cell division failure in p53 À/À HCT116 cells. Moreover, the average length of mitosis in these cells was significantly longer than that of cells that completed a normal, bipolar mitosis (229 vs 36 min, Po0.0001) (Figure 7) . Indeed, some cells spent up to 10 h in spontaneous mitotic arrest before undergoing mitotic slippage (Supplementary Videos S1-S3). These data thus indicate that mitotic slippage after prolonged mitosis can occur spontaneously and are consistent with the possibility that this mechanism of polyploidization may be responsible for the increased structural chromosome instability in polyploid p53 À/À HCT116 cells.
Discussion
Our study shows that in both human colon cancer cells and normal human fibroblasts, p53 suppresses structural chromosome instability after prolonged activation of the mitotic checkpoint. This finding has several important (8N) ; CSB, chromosome break; CSE, chromosome exchange; CTB, chromatid break; CTE, chromatid exchange; Total breaks, CSB þ CTB þ 2(CSE þ CTE), as two breaks produce exchanges; ****, Po0.0001, for w 2 test, as compared with nocodazole-treated p53 þ / þ cells.
p53 and suppression of chromosomal instability WB Dalton et al implications. As (i) certain genetic and epigenetic alterations, which elicit prolonged mitotic checkpoint activation, are causally implicated in tumorigenesis (Dalton and Yang, 2009 ), (ii) prolonged mitosis can provoke DNA breaks (Dalton et al., 2007; Quignon et al., 2007; Stevens et al., 2007) , (iii) DNA breaks can promote tumorigenesis (van Gent et al., 2001) , and (iv) inactivation of p53 is one of the most common oncogenic events in human cancer (Vousden and Lane, 2007) , our findings suggest that suppression of structural chromosome instability after prolonged mitosis may represent a novel mechanism of tumor suppression for p53. Thus, similar to other sources of DNA damage such as replication stress and radiation, prolonged mitotic checkpoint activation may produce potentially oncogenic DNA damage, which necessitates the antitumor activities of p53.
By extension, our data suggest that one function of the p53-dependent postmitotic response may be the suppression of structural chromosome instability. Accordingly, if polyploid cells generated through mitotic slippage evade this p53-dependent response, they may bear an increased risk of promoting cancer, because of genetic alterations acquired during their formation. What is more, polyploid cells may experience further DNA damage during subsequent mitosis, as the presence of supernumerary chromosomes and/or centrosomes itself prolongs activation of the mitotic checkpoint (Yang et al., 2008) . Consistent with this idea, we earlier observed evidence that spontaneous multipolar HCT116 cells, many of which are likely to be polyploid (Stewenius et al., 2005) , may acquire DNA damage during a spontaneously prolonged mitosis (Dalton et al., 2007) . Indeed, inactivation of p53 (8N) ; CSB, chromosome break; CSE, chromosome exchange; CTB, chromatid break; CTE, chromatid exchange; Total breaks, CSB þ CTB þ 2(CSE þ CTE), as two breaks produce exchanges. p53 and suppression of chromosomal instability WB Dalton et al increased the frequency of these damaged multipolar cells (data not shown). Thus, p53-dependent postmitotic arrest may suppress a 'vicious cycle' of structural chromosome instability occurring during the formation-and propagation-of polyploid cells. This may help explain why polyploid cells created through cytokinesis inhibition-and thus without prior mitotic arrest-have increased tumorigenicity in a p53-deficient background (Fujiwara et al., 2005) . Earlier studies have shown that the function of p53 in the regulation of spontaneous structural chromosome integrity is context dependent. For example, increased structural aberrations have been observed in bone marrow cells of p53 À/À mice (Bouffler et al., 1995) and fibroblasts from patients with germline p53 mutations (Bischoff et al., 1990) , but not in lymphoblastoid cells from patients with germline p53 mutations (Lalle et al., 1995) or isogenic human cancer cell lines (Bunz et al., 2002 ) (see Supplementary Information for a discussion of the last example). Similar context dependence has been observed in cytogenetic and comparative genomic hybridization studies of human tumor tissue, as p53 mutations correlate with structural chromosome instability in several case series (De Angelis et al., 1999; Jong et al., 2004; Kleivi et al., 2005) , but not in others (Eshleman et al., 1998; Curtis et al., 2000; Westra et al., 2005) . Interestingly, some of this context dependence may be due to differences in the types of p53 mutations that occur, as there is evidence that gain-of-function p53 mutations are more likely than null p53 mutations to promote structural chromosome instability (Song et al., 2007) . Conversely, much of the complexity may result from the different genetic backgrounds of tissue types and individual tumors in which p53 is mutated. Indeed, several studies have shown that while p53 mutation alone may have minimal effects on structural chromosome instability in certain mouse models, its mutation can greatly exacerbate structural chromosome . In this way, p53 seems to facilitate the underlying tendencies to structural chromosome instability initiated by other defects. From this view, our data suggest that prolonged activation of the mitotic checkpoint may be one such instigator of structural chromosome instability that is facilitated by p53 mutation. Of note, this situation resembles the complexity recently discovered in numerical chromosome instability, in which errors in chromosome missegregation require additional 'aneuploidytolerating' defects to produce stable numerical changes (Thompson and Compton, 2008) .
Our data also have implications for understanding the cellular responses to antimitotic chemotherapeutics. The p53-regulated survival of nocodazole-treated HCT116 cells suggests that p53 can be a determinant of antimitotic chemosensitivity. Indeed, we have also observed that p53 knockdown partially attenuated nocodazole-induced apoptosis in RKO colon cancer cells (unpublished observations). These findings are consistent with earlier reports in HCT116 and MCF-7 cells (Galmarini et al., 2001; Zhang et al., 2002; Yamaguchi et al., 2004; Kienitz et al., 2005; Castedo et al., 2006) . At the same time, studies in other cell systems have found that p53 inactivation confers no change-or even an increase-in antimitotic sensitivity, Con, control cells; Cells, number of cells analyzed from three independent experiments; Chrom, number of chromosomes obtained by multiplying cell number by either 45 chromosomes/cell for diploid (4N), or 90 chromosomes/cell, for polyploid (8N), chromosomes/cell; CSB, chromosome break; CSE, chromosome exchange; CTB, chromatid break; CTE, chromatid exchange; Total breaks, CSB þ CTB þ 2(CSE þ CTE), as two breaks produce exchanges. ****, Po0.0001, for w 2 tests, as compared with diploid p53
Quantification of mitotic cells with polyploid DNA content, as determined by scoring of chromosome spreads. Means and s.e.m.s are from three independent experiments. **, Po0.01 for t-test. (c) Example of chromosome aberrations in a polyploid p53 À/À cell, as determined by color karyotyping. The red underlining indicates an aberration not present in the diploid p53 þ / þ and p53 À/À HCT116 karyotype (Bunz et al., 2002) . Chromosome fragments are also underlined in the lower left. Figure 7 Mitosis is spontaneously prolonged in p53 À/À HCT116 cells, which fail to divide. Dot plot of mitotic length, defined as the interval between the start of mitotic rounding up and anaphase (or mitotic slippage), in cells, which underwent normal, bipolar cell division or which failed to divide; 24 cells in each category were scored, and the mean lengths of mitosis are represented by horizontal lines. ****, Po0.0001 for t-test.
showing the cell-type specificity of this effect (Woods et al., 1995; Minn et al., 1996; Wahl et al., 1996; Tao et al., 2007) . Our own observation that p53 knockdown did not significantly affect nocodazole-induced apoptosis in HDFs is consistent with this idea. This context dependence is likely influenced by the same factors enumerated above for the function of p53 in structural chromosome instability, as tissue of origin and p53 mutation type have earlier been implicated in p53-dependent sensitivity to other chemotherapeutics (Lu and El-Deiry, 2009 ). Thus, a conservative interpretation of these findings is that p53 may be a determinant of antimitotic sensitivity in a subset of human tumors, which also share other modulators of drug sensitivity. Identification of such modulators will be an interesting area for future work, and might include investigations into DNA repair pathways (Swanton et al., 2009) , as well as other p53 family members, such as p63 and p73, both of which are known to influence chemosensitivity (Muller et al., 2006) . Finally, with the ongoing development of pharmaceuticals, which partially restore p53 activity in cancer cells (Lu and El-Deiry, 2009 ), it may be worthwhile to determine whether such agents might work in synergy with antimitotics by restoring p53-dependent apoptotic and growth arrest signaling after prolonged mitotic arrest.
An important but unanswered question is what triggers p53 during this process (Stukenberg, 2004; Chan et al., 2008) . Although an initial proposal was that p53 is activated by a mechanism, which senses, or counts, the presence of a tetraploid genome (Andreassen et al., 2001) , subsequent studies showed that tetraploid cells produced in the absence of prolonged mitosis do not necessarily undergo p53-dependent growth arrest Sluder, 2004, 2007; Wong and Stearns, 2005) . Indeed, the results of our blebbistatin experiment ( Figure 5 ) support the conclusions of these later studies. Another proposal has been that the transcriptional repression, which occurs during mitosis leads to inhibition of p53 degradation, which in turn leads to progressive accumulation of p53 protein during prolonged mitotic arrest (Blagosklonny, 2006) . However, this 'mitotic timer' model for p53 is not supported by studies showing that conditions that dramatically shorten mitotic arrest do not diminish the accumulation of p53 (Vogel et al., 2004; Chan et al., 2008) , nor by data showing that p53 accumulation occurs after, and not during, mitotic arrest (Minn et al., 1996) .
As DNA damage is a well-established activator of p53 (Vousden and Lu, 2002) , it is tempting to speculate that postmitotic activation of p53 is induced, or influenced, by DNA damage acquired during mitotic arrest. Indeed, our finding that loss of p53 increases the burden of chromosome aberrations in nocodazole-induced polyploids-but does not affect the initial acquisition of DNA damage during mitotic arrest-suggests that the p53-dependent postmitotic response preferentially inhibits the most damaged cells. This, in turn, suggests that the extent of DNA damage acquired during prolonged mitosis influences cell fate. In this way, the postmitotic activation of p53 by DNA damage would be analogous to p53 activation after blockage of nucleotide biosynthesis, which, while initially believed to be a non-genotoxic inducer of p53 (Linke et al., 1996) , has recently been shown, with more sensitive assays, to cause DNA damage (Hastak et al., 2008) .
At the same time, it remains possible that DNA damage is one, but not the only, determinant of p53 activation after prolonged mitotic arrest . Indeed, we earlier observed significant cell-type variation in nocodazole-induced g-H2AX foci (Dalton et al., 2007) , which raises the question of whether DNA damage could account for p53 activation after mitotic arrest in all cell types. Along these lines, a lack of increased g-H2AX in nocodazole-treated U20S cells has been reported (Aylon et al., 2006; Chan et al., 2008) . However, multiple studies have now reported evidence that DNA damage accompanies treatments, which induce mitotic arrest in a variety of cell lines (Tighe et al., 2004; Wong and Stearns, 2005; Dalton et al., 2007; Quignon et al., 2007; Stevens et al., 2007; Shi et al., 2008) . Furthermore, it is important to note that a lack of increased g-H2AX does not rule out the presence of DNA damage, as there are DNA lesions, such as single-stranded breaks and base alterations, which do not induce g-H2AX (Rogakou et al., 1998) . In fact, some of the chromatid-type aberrations we observed after prolonged mitotic arrest could result from lesions other than double-stranded breaks (Zhuanzi et al., 2007) . Clearly, future studies into the mechanisms responsible for DNA damage during mitotic arrest will be needed to determine its function in postmitotic p53 activation. Nonetheless, we believe our data show that p53 functions to inhibit the potentially dangerous consequences of DNA damage acquired during mitotic arrest.
Materials and methods
Cell lines and treatments IMR90 HDFs were obtained from the ATCC. p53 þ / þ and p53 À/À HCT116 cells were kindly provided by B Vogelstein (Johns Hopkins Medical Institution, Baltimore, MD, USA). HCT116 cells were cultured in McCoy's and seeded at a density of 3 Â 10 4 cells/cm 2 onto fibronectin-coated dishes or slides 24 h before experiments. IMR90 cells were cultured in Dulbecco 0 s Modified Eagle Medium and also seeded at a density of 3 Â 10 4 cells/cm 2 24 h before experiments. Nocodazole and blebbistatin (Sigma-Aldrich, St Louis, MO, USA) were used at 200 nM and 150 mM, respectively, the minimum concentrations, which completely inhibited cell division in HCT116 cells (data not shown). g-irradiation was performed with a Cs-137 Gammacell. Stealth Select siRNAs targeted to Eg5, control siRNA, and Lipofectamine RNAiMax were obtained from, and used according to the instructions of, Invitrogen (Carlsbad, CA, USA). miRNAs targeting p53, or a non-specific control, were also obtained from Invitrogen, initially as DNA oligos. These oligos were then cloned into the pLenti6-GW/EmGFP-miR lentiviral expression vector (Invitrogen), and these vectors were transfected into 293FT cells along with the pLP/VSVG, pLP1, and pLP2 plasmids (Invitrogen) to produce miRNA-containing lentivirus.
HCT116 and IMR90 were transduced with high-titer virus, and pools of hundreds of blasticidin-resistant colonies were expanded to produce stable knockdown cell lines.
Immunodetection
For immunocytochemistry, cells were fixed with 2% formaldehyde/PBS and permeabilized with 0.2% Triton-X 100. Antibody incubations were 1 h at room temperature, and DNA was counterstained with DAPI. Images were acquired with a Zeiss Axioskop 2 Plus microscope. For MPM-2 flow cytometry, cells were harvested by trypsinization and fixed overnight at À20 1C in 70% ethanol. Antibody incubations were 1 h at room temperature, and DNA was counterstained with propidium iodide. For g-H2AX/CC-3 flow cytometry, cells were harvested by trypsinization, fixed with 2% formaldehyde/PBS, permeabilized with methanol, and incubated overnight at 4 1C with primary antibodies, followed the next day by 1 h incubations with secondary antibodies. Similar to MPM-2, CC-3 is an antibody, which specifically stains mitotic cells, but is an IgG 2a allotype, and can thus be used simultaneously with IgG 1 antibodies, such as g-H2AX (Thibodeau and Vincent, 1991) . Data were acquired using an FACSCalibur (Becton-Dickinson, San Jose, CA, USA) and analyzed with Flowjo. Immunoblotting was performed as described earlier (Yoon et al., 2005) .
The following antibodies were used: mouse anti-g-H2AX (Upstate, Billerica, MA, USA), rat anti-a-tubulin (Chemicon, Temecula, CA, USA), mouse MPM-2 (Upstate), mouse CC-3 (a gift from M. Vincent, Universite´Laval, Que´bec, Qc, Canada), rabbit anti-Eg5 (Abcam, Cambridge, MA, USA), goat anti-p53 (Santa Cruz, Santa Cruz, CA, USA), rabbit anti-cleaved-PARP (Cell Signaling, Danvers, MA, USA), and mouse anti-actin (Sigma-Aldrich). All fluorescent secondary antibodies were Alexa-conjugates (Molecular Probes, Carlsbad, CA, USA).
Cytogenetic analyses
Chromosome spreads were prepared using standard cytogenetic techniques, DNA was stained with DAPI, and images were obtained using a Zeiss Axioskop 2 Plus microscope. Scoring of chromosome aberrations was performed according to the classification system of Savage (Savage, 1976) . Furthermore, all scoring was performed, in which possible, in a blinded manner. For color karyotyping of spontaneous polyploid p53 À/À cells, analysis was performed by Chrombios GmbH (Munich, Germany).
Colony survival
After 48 h nocodazole treatment, HCT116 cells were harvested by trypsinization and seeded into T75 flasks. After 9 days, colonies were stained with methylene blue, photographs of the flasks were taken, and colony number was quantified using Metamorph imaging software. For quantification of untreated control colonies, 1/100 the number of cells used in nocodazoletreated samples were seeded into T75 flasks and colony number was normalized accordingly, as use of the same number of cells as nocodazole-treated samples produced colonies, which were too dense to be quantified (Figure 2f ).
Time-lapse imaging
Phase-contrast images of p53 À/À HCT116 cells grown inside a 37 1C, 5% CO 2 chamber were automatically obtained at 6 min intervals in multiple locations over 48 h using an Olympus IX81 microscope. All images were analyzed with Slidebook.
